Company Analysis

Insight Molecular Diagnostics Inc. (IMDX)

Nasdaq: IMDX · In Vitro & In Vivo Diagnostic Substances · Nashville, TN · filing with the SEC since 2015
Grade4.7
◀ Past 3.6● Present 2.9▶ Future 7.1
1 est.

Filings

383 filings since 2017 beside 231 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.

Filings a yearinsider forms included
6784838260684832
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 8 times in the last 36 months, the newest Jun 17, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Apr 17, 2025.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Jul 12, 2024.SEC letters: 8 in the last 36 months, the newest Apr 4, 2025.A late-filing notice, Form NT 10-K, filed Apr 1, 2024.
Insider forms 231

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Sep 21, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Sep 15, 2026
Aug 10, 2026 10-Q Quarterly report Jun 30, 2026
Aug 10, 2026 8-K items 2.02, 7.01, 8.01, 9.01 Results released; Investor disclosure (Regulation FD); Other event · Current report
Jul 24, 2026 S-8 Employee stock plan registration
Jun 17, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report Jun 11, 2026
May 13, 2026 10-Q Quarterly report Mar 31, 2026
May 13, 2026 8-K items 2.02, 9.01 Results released · Current report
May 13, 2026 8-K/A item 8.01 Other event · Current report, amended Feb 20, 2026
Apr 30, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 30, 2026 DEFA14A Extra proxy material
Apr 30, 2026 DEF 14A Proxy statement
Apr 30, 2026 8-K items 8.01, 9.01 Other event · Current report
Apr 27, 2026 SCHEDULE 13D/A Activist holder update, amended
Mar 26, 2026 10-K Annual report Dec 31, 2025
Mar 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 26, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Feb 20, 2026
Feb 12, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Feb 10, 2026
Feb 12, 2026 SCHEDULE 13D/A Activist holder update, amended
Feb 11, 2026 424B5 Shelf offering
Feb 11, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Nov 10, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 10, 2025 10-Q Quarterly report Sep 30, 2025
Oct 2, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Sep 28, 2025
Sep 19, 2025 8-K item 5.02 Officer or director change · Current report Sep 16, 2025
Aug 18, 2025 S-8 Employee stock plan registration
Aug 11, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 11, 2025 10-Q Quarterly report Jun 30, 2025
Jul 2, 2025 8-K item 5.07 Shareholder vote · Current report Jun 27, 2025
Jun 17, 2025 8-K items 5.03, 7.01, 9.01 Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report Jun 13, 2025
May 14, 2025 ARS Annual report to shareholders Dec 31, 2024
May 14, 2025 DEFA14A Extra proxy material
May 14, 2025 DEF 14A Proxy statement
May 12, 2025 8-K items 2.02, 9.01 Results released · Current report
May 12, 2025 10-Q Quarterly report Mar 31, 2025
May 9, 2025 SCHEDULE 13G/A Large holder update, amended
Apr 17, 2025 8-K items 4.01, 9.01 Auditor change · Current report Apr 11, 2025
Apr 8, 2025 424B3 Shelf offering
Apr 7, 2025 EFFECT Registration effective
Apr 4, 2025 CORRESP Reply to the SEC
Apr 3, 2025 UPLOAD SEC comment letter
40 of 383 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton IMDX · research, not advice